139481-72-4,MFCD08436154
Catalog No.:AA007Z5Y

139481-72-4 | Trityl candesartan

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$15.00   $11.00
- +
1g
97%
in stock  
$38.00   $27.00
- +
5g
97%
in stock  
$116.00   $81.00
- +
25g
97%
in stock  
$388.00   $271.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA007Z5Y
Chemical Name:
Trityl candesartan
CAS Number:
139481-72-4
Molecular Formula:
C43H34N6O3
Molecular Weight:
682.7685
MDL Number:
MFCD08436154
SMILES:
CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1nnnn1C(c1ccccc1)(c1ccccc1)c1ccccc1)c(ccc2)C(=O)O
Properties
Computed Properties
 
Complexity:
1090  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
52  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
11  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
8.9  

Upstream Synthesis Route

[1]Patent:CN105153124,2018,B,.Locationinpatent:Paragraph0005;0054;0055;0076;0090

[2]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn13

[3]Patent:US2010/210852,2010,A1,.Locationinpatent:Page/Pagecolumn5

[4]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn14

[5]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn14

[6]Patent:WO2007/94015,2007,A1,.Locationinpatent:Page/Pagecolumn5-6

[7]Patent:EP1833801,2008,B1,.Locationinpatent:Page/Pagecolumn18

[8]BioorganicandMedicinalChemistry,2009,vol.17,#23,p.7971-7977

[9]Patent:WO2006/50922,2006,A1,.Locationinpatent:Page/Pagecolumn12

[10]Patent:WO2009/157001,2009,A2,.Locationinpatent:Page/Pagecolumn4

[11]Patent:WO2011/92666,2011,A1,.Locationinpatent:Page/Pagecolumn12

[12]Patent:WO2011/145100,2011,A1,.Locationinpatent:Page/Pagecolumn7-8

[13]Patent:US2018/155326,2018,A1,.Locationinpatent:Paragraph0031-0034

[1]Patent:US5196444,1993,A,

[1]Patent:US6177587,2001,B1,

[1]Patent:WO2011/145100,2011,A1,

[1]Patent:WO2011/145100,2011,A1,

Downstream Synthesis Route

[1]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn13-14

[1]Patent:US2009/247595,2009,A1.Locationinpatent:Page/Pagecolumn4

[2]Patent:WO2008/12371,2008,A1.Locationinpatent:Page/Pagecolumn20;21

[3]Patent:CN105153124,2018,B.Locationinpatent:Paragraph0006;0063;0080;0094

[4]Patent:US2010/210852,2010,A1.Locationinpatent:Page/Pagecolumn6

[5]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14-15

[6]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn9

[7]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn9-10

[8]Patent:WO2006/50922,2006,A1.Locationinpatent:Page/Pagecolumn12

[9]Patent:WO2007/94015,2007,A1.Locationinpatent:Page/Pagecolumn6-7

[10]Patent:WO2009/157001,2009,A2.Locationinpatent:Page/Pagecolumn4-5

[11]Patent:WO2011/92666,2011,A1.Locationinpatent:Page/Pagecolumn15

ethylacetate-benzene 
  76-83-5    139481-59-7    139481-72-4 

[1]Patent:US5196444,1993,A

[1]Patent:US5196444,1993,A

[1]Patent:CN105153124,2018,B.Locationinpatent:Paragraph0005;0054;0055;0076;0090

[2]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn13

[3]Patent:US2010/210852,2010,A1.Locationinpatent:Page/Pagecolumn5

[4]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14

[5]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14

[6]Patent:WO2007/94015,2007,A1.Locationinpatent:Page/Pagecolumn5-6

[7]Patent:EP1833801,2008,B1.Locationinpatent:Page/Pagecolumn18

[8]BioorganicandMedicinalChemistry,2009,vol.17,p.7971-7977

[9]Patent:WO2006/50922,2006,A1.Locationinpatent:Page/Pagecolumn12

[10]Patent:WO2009/157001,2009,A2.Locationinpatent:Page/Pagecolumn4

[11]Patent:WO2011/92666,2011,A1.Locationinpatent:Page/Pagecolumn12

[12]Patent:WO2011/145100,2011,A1.Locationinpatent:Page/Pagecolumn7-8

[13]Patent:US2018/155326,2018,A1.Locationinpatent:Paragraph0031-0034

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:139481-72-4 Molecular Formula|139481-72-4 MDL|139481-72-4 SMILES|139481-72-4 Trityl candesartan
Catalog No.: AA007Z5Y
139481-72-4,MFCD08436154
139481-72-4 | Trityl candesartan
Pack Size: 250mg
Purity: 97%
in stock
$15.00 $11.00
Pack Size: 1g
Purity: 97%
in stock
$38.00 $27.00
Pack Size: 5g
Purity: 97%
in stock
$116.00 $81.00
Pack Size: 25g
Purity: 97%
in stock
$388.00 $271.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA007Z5Y
Chemical Name: Trityl candesartan
CAS Number: 139481-72-4
Molecular Formula: C43H34N6O3
Molecular Weight: 682.7685
MDL Number: MFCD08436154
SMILES: CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1nnnn1C(c1ccccc1)(c1ccccc1)c1ccccc1)c(ccc2)C(=O)O
Properties
Complexity: 1090  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 52  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 11  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 8.9  
Upstream Synthesis Route
76-83-5    139481-59-7    139481-72-4 

[1]Patent:CN105153124,2018,B,.Locationinpatent:Paragraph0005;0054;0055;0076;0090

[2]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn13

[3]Patent:US2010/210852,2010,A1,.Locationinpatent:Page/Pagecolumn5

[4]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn14

[5]Patent:WO2009/7986,2009,A1,.Locationinpatent:Page/Pagecolumn14

[6]Patent:WO2007/94015,2007,A1,.Locationinpatent:Page/Pagecolumn5-6

[7]Patent:EP1833801,2008,B1,.Locationinpatent:Page/Pagecolumn18

[8]BioorganicandMedicinalChemistry,2009,vol.17,#23,p.7971-7977

[9]Patent:WO2006/50922,2006,A1,.Locationinpatent:Page/Pagecolumn12

[10]Patent:WO2009/157001,2009,A2,.Locationinpatent:Page/Pagecolumn4

[11]Patent:WO2011/92666,2011,A1,.Locationinpatent:Page/Pagecolumn12

[12]Patent:WO2011/145100,2011,A1,.Locationinpatent:Page/Pagecolumn7-8

[13]Patent:US2018/155326,2018,A1,.Locationinpatent:Paragraph0031-0034

76-83-5    139481-59-7    139481-72-4 

[1]Patent:US5196444,1993,A,

821-25-0    76-83-5    139481-59-7    139481-72-4 

[1]Patent:US6177587,2001,B1,

21606-04-2    139481-72-4 

[1]Patent:WO2011/145100,2011,A1,

57113-90-3    139481-72-4 

[1]Patent:WO2011/145100,2011,A1,

Downstream Synthesis Route
139481-72-4    145040-37-5 

[1]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn13-14

139481-72-4    99464-83-2    170791-09-0 

[1]Patent:US2009/247595,2009,A1.Locationinpatent:Page/Pagecolumn4

[2]Patent:WO2008/12371,2008,A1.Locationinpatent:Page/Pagecolumn20;21

[3]Patent:CN105153124,2018,B.Locationinpatent:Paragraph0006;0063;0080;0094

[4]Patent:US2010/210852,2010,A1.Locationinpatent:Page/Pagecolumn6

[5]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14-15

[6]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn9

[7]Patent:WO2005/37821,2005,A2.Locationinpatent:Page/Pagecolumn9-10

[8]Patent:WO2006/50922,2006,A1.Locationinpatent:Page/Pagecolumn12

[9]Patent:WO2007/94015,2007,A1.Locationinpatent:Page/Pagecolumn6-7

[10]Patent:WO2009/157001,2009,A2.Locationinpatent:Page/Pagecolumn4-5

[11]Patent:WO2011/92666,2011,A1.Locationinpatent:Page/Pagecolumn15

ethylacetate-benzene 
  76-83-5    139481-59-7    139481-72-4 

[1]Patent:US5196444,1993,A

139481-72-4   
1N-HCl 
  95789-69-8    145040-37-5 

[1]Patent:US5196444,1993,A

76-83-5    139481-59-7    139481-72-4 

[1]Patent:CN105153124,2018,B.Locationinpatent:Paragraph0005;0054;0055;0076;0090

[2]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn13

[3]Patent:US2010/210852,2010,A1.Locationinpatent:Page/Pagecolumn5

[4]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14

[5]Patent:WO2009/7986,2009,A1.Locationinpatent:Page/Pagecolumn14

[6]Patent:WO2007/94015,2007,A1.Locationinpatent:Page/Pagecolumn5-6

[7]Patent:EP1833801,2008,B1.Locationinpatent:Page/Pagecolumn18

[8]BioorganicandMedicinalChemistry,2009,vol.17,p.7971-7977

[9]Patent:WO2006/50922,2006,A1.Locationinpatent:Page/Pagecolumn12

[10]Patent:WO2009/157001,2009,A2.Locationinpatent:Page/Pagecolumn4

[11]Patent:WO2011/92666,2011,A1.Locationinpatent:Page/Pagecolumn12

[12]Patent:WO2011/145100,2011,A1.Locationinpatent:Page/Pagecolumn7-8

[13]Patent:US2018/155326,2018,A1.Locationinpatent:Paragraph0031-0034

Building Blocks More >
13511-11-0
13511-11-0
3,3'-Dimethyltriphenylamine
AA007ZN9 | MFCD23115649
13610-59-8
13610-59-8
3-(2-Oxo-2,3-dihydro-1,3-benzoxazol-3-yl)propanoic acid
AA008062 | MFCD00052166
1211590-25-8
1211590-25-8
6-Chloro-3-(trifluoromethyl)-1h-pyrazolo[3,4-d]pyrimidine
AA0080KU | MFCD18254709
1184990-35-9
1184990-35-9
4-[N-(Methyl-d3)-N-nitrosamino]-4-(3-pyridyl)butane-1-ol
AA00811U | MFCD25974337
1117776-68-7
1117776-68-7
4-Allyloxyphenylboronic acid
AA0081PZ | MFCD11103728
111362-49-3
111362-49-3
Benzamide, 5-amino-2-chloro-N-methyl-
AA0082FF | MFCD09044637
108715-56-6
108715-56-6
[2-(3-Phenylpropoxy)phenyl]amine hydrochloride
AA008379 | MFCD08559357
1082745-50-3
1082745-50-3
5-Amino-1-(tetrahydro-2h-pyran-4-yl)-1h-pyrazole-4-carboxamide
AA0083SH | MFCD12405839
105995-73-1
105995-73-1
2-Bromo-5-ethynylthiophene
AA0084K3 | MFCD08703509
103986-22-7
103986-22-7
6-Methoxyindole-3-acetic acid
AA00853A | MFCD01548400
Submit
© 2017 AA BLOCKS, INC. All rights reserved.